...
机译:ERCC1-C118T和-C8092A多态性与肺癌风险和肺癌患者患者的肺癌危险和存活率接受铂类化疗:基于39报告的汇总分析
Department of Oncology The First Affiliated Hospital of Nanjing Medical University No. 300;
Department of Oncology The First Affiliated Hospital of Nanjing Medical University No. 300;
Department of Oncology The First Affiliated Hospital of Nanjing Medical University No. 300;
Department of Oncology The First Affiliated Hospital of Nanjing Medical University No. 300;
Chemotherapy; ERCC1; Meta-analysis; Platinum; Prognosis; Risk;
机译:ERCC1-C118T和-C8092A多态性与肺癌风险和肺癌患者患者的肺癌危险和存活率接受铂类化疗:基于39报告的汇总分析
机译:ERCC1 C118T / C8092A和MDR1 C3435T的多态性预测晚期非小细胞肺癌中铂类化学疗法的结果:一项荟萃分析。
机译:铂类化学疗法治疗非小细胞肺癌患者CASP7基因多态性与生存的关系
机译:接受酪氨酸激酶抑制剂治疗的EGFR突变非小细胞肺癌患者肿瘤异质性与无进展生存的关系
机译:导致晚期非小细胞肺癌患者营养风险的症状:在晚期肺癌人群中进行营养筛查的重要性
机译:非小细胞肺癌铂类化学疗法的核苷酸切除修复基因多态性与预后:基于44项研究的荟萃分析
机译:甲基四氢盐还原酶C677T多态性对肺癌风险的影响及对铂基化疗的高小细胞肺癌的临床反应:更新的荟萃分析